SGYP Related FDA
-
Synergy (SGYP) Higher After Plecanatide Meets Endpoints
-
Synergy Pharma (SGYP) Initiates SP-333 Phase I in UC
-
Synergy Pharma (SGYP) Files IND for SP-333
-
UPDATE: Synergy Pharma (SGYP) Higher on Linzess Approval (IRWD) (FRX)
-
Synergy (SGYP) Hits Halfway Enrollment Milestone in Plecanatide Phase II/III
Back to SGYP Stock Lookup
